Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.085 USD | -5.66% | -7.61% | -35.61% |
May. 20 | Immunome Completes Purchase of Antibodies From Atreca | MT |
May. 20 | Immunome, Inc. completed the acquisition of Substantially all Assets of Atreca, Inc.. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.61% | 3.37M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- BCEL Stock
- News Atreca, Inc.
- Jefferies Lowers Atreca's Price Target to $14 From $17, Maintains Buy Rating